刘丹
首都医科大学附属北京天坛医院 · 药学部 · 药师 · 药学。
擅长领域
专家简介
研究方向：1. 神经系统罕见病的药物临床评价与全程化用药管理；2. 纳米靶向药物递送系统的研究
教育经历
2014.09-2018.06：河北大学，本科
2018.09-2021.06：北京协和医学院，硕士
2021.09-2024.06：北京协和医院，博士
工作经历
2024.08 - 至今：首都医科大学附属北京天坛医院，药学部
社会兼职
无
文章及课题发布（近五年）
Dan Liu, Shuang Liang, Kongshuo Ma, Qian-Fang Meng, Xingang Li, Jian Wei, Mengli Zhou, Kaiqing Yun, Yuanwei Pan, Lang Rao*, Xiaoyuan Chen*, Zhaohui Wang*. Tumor microenvironment-responsive nanoparticles amplifying STING signaling pathway for cancer immunotherapy[J]. Advanced Materials, 2024, 36(6), 2304845.
Dan Liu", Shuang Liang", Kongshuo Ma, Kaiqing Yun, Mengli Zhou, Linna Hai, Yuxuan Peng, Zhaohui Wang*. A bi-adjuvant nanocomposite amplifying STING activation for cancer immunotherapy[J]. Nano Today, 2024, 57, 102372.
Dan Liu, Bo Deng, Zongran Liu, Bing Ma, Xiang Leng, Deling Kong, Tianjiao Ji*, Lanxia Liu*. Enhanced antitumor immune responses via a self-assembled carrier-free nanovaccine[J]. Nano Letters, 2021, 21(9), 3965-3973.
Dan Liu, Jiale Liu, Bing Ma, Bo Deng, Xigang Leng, Deling Kong, Lanxia Liu*. A simple self-adjuvanting biomimetic nanovaccine self-assembled with the conjugate of phospholipids and nucleotides can induce a strong cancer immunotherapeutic effect[J]. Biomaterials Science, 2021, 9(1), 84-92.
Jing Zhang", Dan Liu", Jiale Liu, Yanfeng Han, Haiyan Xu, Xigang Leng, Deling Kong, Lanxia Liu*. Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades[J]. Biomaterials Science, 2020, 8(17), 4757-4766.